Vaccine stands for a preparation of dead, attenuate or else modified viruses, bacteria and other microorganisms utilized as an inoculation to immunize against any disease by way of stimulating antibodies’ production. With constant technology upgrades and launches of new medicinal products, Vaccines proved to be the most sophisticated healthcare aid ever created in the pharma’s history.
The global Vaccine Industry is thriving mainly owing to the chronic availability of different diseases, both already-existing and cropping up on the horizon, which can be luckily prevented with Vaccines’ assistance. Pediatric Vaccines form the largest and the most hastily evolving segment as against adult Vaccines, with the trend predicted to stay unaltered in the impending period. The worldwide Vaccine Market is primarily in the paws of such behemoths as Merck & Company, Inc.; Novartis, Pfizer, Inc.; GlaxoSmithKline plc; and Sanofi Pasteur.
The research reports under this Catalogue provide in-depth assessments of the global Vaccine Industry, discussing pressing market issues and statistical figures. The research reports cover the sizing (value/volume) and short-to-long-run forecasts for the overall Vaccine Market and its major segments, and for numerous geographic markets. The listing of M&As among the Vaccine universe participants with new products’ reviews, alongside company profile information can be derived from the research reports too.
Publications found:
471
Sort by:
Global Influenza Market – Vaccines and Therapeutics
US$ 4,500.00
... a robust 8.5% CAGR between 2016 and 2022. Vaccines account for about 80% of the influenza market while therapeutics account for the remaining ... analyses and projects the Influenza therapeutics market at the global level while vaccines market is explored in and the regional markets including North America, Europe ...
April 2025
387 pages
Saudi Arabia Influenza Vaccine Market By Vaccine Type (Inactivated Influenza Vaccine, Live Attenuated Influenza Vaccine), By Distribution Channel (Hospital, Retail Pharmacies, Government Suppliers, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F
US$ 3,500.00
Saudi Arabia Influenza Vaccine Market was valued at USD 44.26 Million in 2024 and is expected to reach USD 53.81 Million by 2030 with a CAGR of 3.51% during the forecast period. The vaccine available...
January 2025
85 pages
Influenza Vaccines Market, Persons Vaccinated, By Segment – Vaccine Type, Indication, Technology, Route of Administration, End-user, Geography, Company Analysis - Global Forecast (2025 - 2032)
US$ 2,690.00
The global influenza vaccines market is projected to reach US$ 12.16 Billion by 2032, from US$ 7.60 Billion in 2024. Influenza is a highly communicable disease and typically has the most severe impact...
January 2025
388 pages
Tetanus Toxoid Vaccine Market Size, Share & Trends Analysis Report By Vaccine (Diphtheria, Tetanus, And Pertussis (DTaP)), By Disease (Tetanus, Diphtheria), By End Use (Hospital, Specialty Clinics), By Region, And Segment Forecasts, 2025 - 2030
US$ 5,950.00
This report can be delivered to the clients within 3 Business Days Tetanus Toxoid Vaccine Market Growth & Trends The global tetanus toxoid vaccine market size is anticipated t%li%reach USD 8.09 bill...
January 2025
153 pages
Travel Vaccines Market Report by Composition (Mono Vaccines, Combination Vaccines), Disease (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, and Others), and Region 2025-2033
US$ 2,999.00
The global travel vaccines market size reached USD 4.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 10.0 Billion by 2033, exhibiting a growth rate (CAGR) of 9.36% duri...
January 2025
129 pages
International Trade in Antisera and Other Blood Fractions: Trends and Prospects
US$ 820.00
The reports examine global antisera and other blood fractions market trends (historical, current and forecast) with respect to international trade including antisera and other blood fractions global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
October 2024
170 pages
International Trade in Vaccines, Human Use: Trends and Prospects
US$ 820.00
The reports examine global vaccines, human use market trends (historical, current and forecast) with respect to international trade including vaccines, human use global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
October 2024
90 pages
International Trade in Vaccines, Veterinary Use: Trends and Prospects
US$ 820.00
The reports examine global vaccines, veterinary use market trends (historical, current and forecast) with respect to international trade including vaccines, veterinary use global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
October 2024
90 pages